Radiolabeling of the rat P2X4 purinoceptor: Evidence for allosteric interactions of purinoceptor antagonists and monovalent cations with P2X purinoceptors

Molecular Pharmacology

Volumn 51, Issue 3, 1997, Pages 524-532

  Michel, Anton D ^a   Miller, Kerry J ^a   Lundström, Kenneth ^b   Buell, Gary N ^c   Humphrey, Patrick P A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXO INST FOR MOLECULAR BIOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; CIBACRON BLUE F3GA; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL 5 PHOSPHATE; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; SODIUM ION; SURAMIN; TUBOCURARINE CHLORIDE; PURINE RECEPTOR; SODIUM CHLORIDE; SULFUR;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CHANNEL GATING; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; AFFINITY LABELING; ANIMAL; BINDING COMPETITION; CHEMISTRY; DRUG ANTAGONISM; GENETIC TRANSFECTION; HAMSTER; KINETICS; METABOLISM; PROTEIN BINDING; RAT;

ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; KINETICS; PROTEIN BINDING; RATS; RECEPTORS, PURINERGIC; RECOMBINANT PROTEINS; SODIUM CHLORIDE; SULFUR RADIOISOTOPES; TRANSFECTION; TUBOCURARINE;

EID: 0030614993     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Valera, S., N. Hussy, R. J. Evans, N. Adami, R. A. North, A. Surprenant, and G. Buell. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature (Lond.) 371:516-519 (1994).
2. Brake, A. J., M. J. Wagenbach, and D. Julius. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature (Lond.) 371:519-523 (1994).
3. Lewis, C., S. Neidhart, C. Holy, R. A. North, G. Buell, and A. Surprenant. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature (Lond.) 377:432-435 (1995).
4. Chen, C. C., A. N. Akopian, L. Sivilotti, D. Colquhoun, G. Burnstock, and J. N. Wood. A P2X purinoceptor expressed by a subset of sensory neurons. Nature (Lond.) 377:428-431 (1995).
5. Buell, G., C. Lewis, G. Collo, R. A. North, and A. Surprenant. An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 15:55-62 (1996).
6. Bo, X., Y. Zhang, M. Nassar, G. Burnstock, and R. Schoepfer. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375:129-133 (1995).
7. Collo, G., R. A. North, E. Kawashima, E. Merlopich, S. Neidhart, A. Surprenant, and G. Buell. Cloning of P2X(5) and P2X(6) receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16:2495-2507 (1996).
8. Surprenant, A., F. Rassendren, E. Kawashima, R. A. North, and G. Buell. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (Washington D. C.) 272:735-738 (1996).
9. 33P]-ATP. Br. J. Pharmacol. 117:1254-1260 (1996).
10. 2X2 purinoceptors. Br. J. Pharmacol. 118:1806-1813 (1996).
11. Liljestrom, P., and H. Garoff. A new generation of animal cell expression vectors based on the Semliki forest virus replicon. Biotechnology 9:1356-1361 (1991).
12. Lundstrom, K., A. Mills, G. Buell, E. Allet, N. Adami, and P. Liljestrom. High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system. Eur. J. Biochem. 224:917-921 (1994).
13. 35S]-adenosine 5′-O-[3-thiotriphosphate] in rat vas deferens membranes. Br. J. Pharmacol. 117:63-70 (1996).
14. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239 (1980).
15. 3H]alpha, beta-methylene ATP binding in rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 350:113-122 (1994).
16. 35S]ATPγS. Br. J. Pharmacol. 117:18P (1996).
17. Nakazawa, K., K. Inoue, K. Fujimori, and A. Takanaka. Effects of ATP antagonists on purinoceptor-operated inward currents in rat phaeochromocytoma cells. Pflueg. Arch. Eur. J. Physiol. 418:214-219 (1991).
18. Stockton, J. M., N. J. Birdsall, A. S. Burgen, and E. C. Hulme. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23:551-557 (1983).
19. Lazareno, S., and N. J. Birdsall. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48:362-378 (1995).
20. 3H]alpha,beta-methylene ATP binding sites in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 348:608-617 (1993).
21. Palea, S., C. Pietra, D. G. Trist, W. Artibani, A. Calpista, and M. Corsi. Evidence for the presence of both pre-and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder. Br. J. Pharmacol. 114:35-40 (1995).
22. Blakeley, A. G., J. E. Brockbank, S. S. Kelly, and S. A. Petersen. Effects of suramin on the concentration-response relationship of alpha,beta-methylene ATP on the mouse vas deferens. J. Auton. Pharmacol. 11:45-49 (1991).
23. Bültmann, R., and K. Starke. Evans blue blocks P2X-purinoceptors in rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 348:684-687 (1993).
24. Mallard, N., R. Marshall, A. Sithers, and B. Spriggs. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens. Eur. J. Pharmacol. 220:1-10 (1992).
25. Barajas-Lopez, C., M. Barrientos, and R. Espinosa-Luna. Suramin increases the efficacy of ATP to activate an inward current in myenteric neurons from guinea-pig ileum. Eur. J. Pharmacol. 250:141-145 (1993).
26. Trezise, D. J., I. Kennedy, and P. P. Humphrey. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha,beta-methylene adenosine 5′-triphosphate. Br. J. Pharmacol. 112:282-288 (1994).